Health News
Date: Oct-02-2012
Knowing how tumors evolve can lead to new treatments that could help prevent cancer from recurring, according to a study published by the Translational Genomics Research Institute (TGen) and Scottsdale Healthcare. TGen researchers tracked several years of tumor evolution in a 47-year-old male patient with maxillary sinus carcinoma (MSC), a rare cancer of the sinus cavities beneath the cheeks that often requires surgical removal that is disfiguring. Fewer than half of MSC patients live more than 5 years after diagnosis...
Date: Oct-02-2012
We couldn't live without our immune systems, always tuned to detect and eradicate invading pathogens and particles. But sometimes the immune response goes overboard, triggering autoimmune diseases like lupus, asthma or inflammatory bowel disease. A new study led by University of Pennsylvania researchers has now identified a crucial signaling molecule involved in counterbalancing the immune system attack. "The immune response is like driving a car," said Christopher Hunter, professor and chair in the Department of Pathobiology in Penn's School of Veterinary Medicine...
Date: Oct-02-2012
You've probably never given much thought to the fact that picking up your cup of morning coffee presents your brain with a set of complex decisions. You need to decide how to aim your hand, grasp the handle and raise the cup to your mouth, all without spilling the contents on your lap. A new Northwestern University study shows that, not only does your brain handle such complex decisions for you, it also hides information from you about how those decisions are made...
Date: Oct-02-2012
The statistics show that efforts to reduce heart disease deaths are successful, with mortality now falling in most of the continent. At the same time, the report shows the huge burden CVD presents to Europe's health, and suggests that underlying factors may cause CVD to increase in the near future. The figures show some progress. Since the 2008 report there has been a substantial drop in the number of deaths attributed to heart disease. CVD is now responsible for four million European deaths annually, down from 4...
Date: Oct-02-2012
Screening practices for multidrug-resistant organisms (MDROs) in intensive care units (ICUs) vary widely from hospital to hospital, according to a new study published in the October issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC)...
Date: Oct-02-2012
A kind of anti-tumor immune cell that can help fight obesity and the metabolic syndrome that causes diabetes has been discovered by researchers at Trinity College in Dublin. According to the report published in Immunity, by Marie Curie Fellow and Lydia Lynch from Trinity College, Dublin Ireland, along with experts from Beth Israel Deaconess Medical Centre and St Vincent's University Hospital, invariant natural killer T-cells (iNKT), immune cells that fight malignancy, disappear when humans become overweight, but can be restored after losing weight...
Date: Oct-01-2012
Ever since we have routinely added synthetic chemicals to everyday household and personal care products, the breast cancer rate among women in the UK has risen dramatically, says Breast Cancer UK, a British charity. According to the UK office for National Statistics, in 1971 out of 100,000 women, only 66 got breast cancer, in 2010 the figure jumped to 126 per 100,000 - an increase of nearly 100%. However, since screening was introduced in 1987, the number of women dying from the disease has been falling steadily...
Date: Oct-01-2012
Researchers have found that high cholesterol is due to a predecessor that inhibits inflammatory response genes. This new precursor molecule could provide a new objective for drugs aimed at treating atherosclerosis. Atherosclerosis is a condition characterized by the hardening of the arteries and is the leading cause of cardiovascular disease and death. This condition has long been believed to be the result of a complex interaction between excess cholesterol and swelling in the heart and blood vessels. It kills tens of thousands of Americans annually...
Date: Oct-01-2012
A critical overview that highlights ways to prevent invasive cervical cancer was recently published in Cancer Epidemiology, Biomarkers & Prevention. Anna R. Giuliano, Ph.D., director of Moffitt's Center for Infection Research in Cancer and senior member of the Cancer Epidemiology Department, explained: "The good news is that over the past several decades, the incidence of invasive cervical cancer has declined dramatically...
Date: Oct-01-2012
Patients in early-stage HER2-positive breast cancer should remain on Herceptin (trastuzumab) treatment for one year, and not two years or six months, according to a final analysis of the Phase III HERA trial, pharmaceutical company Roche and the Breast International Group announced today. Experts say that had the trial found six months of Herceptin was better than one year, Swiss pharmaceutical giant, Roche would have lost approximately $1.5 billion in revenue from this medication. Herceptin is a breast cancer blockbuster medication with sales last year of $5.5 billion...